SCHEMBL5699294

SCHEMBL5699294

CCCCCCCCCCCCCCC(C(=O)OCC)c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.44
ESR2 Q92731 3/20 0.44
HSD17B3 P37058 6/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
LMNA P02545 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
NR1H2 P55055 1/20 0.43
RNASEL Q05823 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH2 P05091 1/20 0.43
NR5A1 Q13285 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5699327 1.00 ESR1 (0.44) ESR1ESR2HSD17B3CA12CA1
SCHEMBL2384369 1.00 ESR1 (0.44) ESR1ESR2HSD17B3CA12CA1
SCHEMBL5699336 1.00 ESR1 (0.44) ESR1ESR2HSD17B3CA12CA1
SCHEMBL10410232 0.94 ESR1 (0.46) ESR1ESR2HSD17B3CA12CA1
SCHEMBL2417275 0.92 PSMB11 (0.48) CYP1A2MAPK1CYP2C19TRPV1KDM4E
SCHEMBL2417274 0.92 PSMB11 (0.48) CYP1A2MAPK1CYP2C19TRPV1KDM4E
SCHEMBL28920116 0.89 MEN1 (0.47) LMNATSHRMAPK1SMN1; SMN2MMP9
SCHEMBL9090315 0.87 ALDH1A1 (0.49) LMNACYP1A2CYP2D6TSHRMAPK1
SCHEMBL8818975 0.86 MMP8 (0.48) LMNATSHRSMN1; SMN2ALDH1A1MMP8
SCHEMBL4886826 0.86 MMP8 (0.48) LMNATSHRSMN1; SMN2ALDH1A1MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516866-B1 NATURAL COMPOUNDS AND DERIVATIVES THEREOF FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR, HEPATIC AND RENAL DISEASES AND FOR COSMETIC APPLICATIONS PULEVA BIOTECH SA (ES) 2006-07-12 EP claimed